Skip to content

Aignostics vs OWKIN

Aignostics logo

Aignostics

AI-powered tissue analysis, validated by pathologists

106 employees · est. 2018 · Berlin, Germany

VS
OWKIN logo

OWKIN

From token to patient impact

396 employees · est. 2016 · New York, United States

OWKIN is the older company (2018 vs 2016); OWKIN is the larger of the two.

Side-by-Side Comparison

Aignostics OWKIN
Founded
2018 2016 older
Headquarters
Berlin, Germany New York, United States
Employees
106 396 larger
Industry
AI, Health Care, Machine Learning AI, Biotechnology, Pharmaceutical
Funding Stage
Series B Not tracked yet
Total Funding
$53.80M $341.30M
Funding Rounds
6 10
Services
Target & Biomarker Discovery, Translational Research, Digital Diagnostics, Custom Image and Data Analysis AI Scientist development, Clinical trial decision support, Biopharmaceutical R&D insights, Precision diagnostic testing, Biopharma autonomous systems
Target Customers
Life Sciences Companies, Academic Institutions, Healthcare Providers, Research Organizations Pharmaceutical companies, Biotech firms, Clinical researchers, Oncologists, Healthcare data scientists
Taxonomy
AI-powered Precision DiagnosticsMultimodal Clinical DatasetsPrecision MedicineDigital PathologyExplainable AIImmuno-oncology +9 AI-powered Drug DiscoveryGenerative BiologyBiological Reasoning SystemsClosed-loop AI SystemsMultimodal Data AnalysisBiopharma Partnerships +8
Website
aignostics.com owkin.com
Aignostics logo

About Aignostics

Aignostics, established in 2018 as a spin-off from Charité Berlin, leverages AI and machine learning to drive advancements in precision diagnostics for pathology. Their innovative platform provides unparalleled insights across various therapeutic areas, making a significant impact on drug discovery,...

OWKIN logo

About OWKIN

OWKIN is a pioneering company at the intersection of AI and Biotechnology, founded in 2016 and headquartered in the United States. It positions itself as the first closed-loop AI generative biology firm, striving to set a new standard in biological reasoning. By developing the first BASI to revoluti...

Also comparing in this category

Comparing more than these two?

Get Aignostics, OWKIN and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does Aignostics compare?

A PDF of Aignostics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

Aignostics was founded in 2018, based in Berlin, Germany, with 106 employees. Aignostics, established in 2018 as a spin-off from Charité Berlin, leverages AI and machine learning to drive advancements in precision diagnostics for pathology. Their innovative platform provides un. OWKIN was founded in 2016, based in New York, United States, with 396 employees. OWKIN is a pioneering company at the intersection of AI and Biotechnology, founded in 2016 and headquartered in the United States. It positions itself as the first closed-loop AI generative biology fi.
Aignostics has raised $53.80M and OWKIN $341.30M. Latest stage: Aignostics Series B.
Both work in AI and Machine Learning and list digital pathology among their focus areas.

Compare Aignostics with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Aignostics on 15 Jun 2026, and OWKIN on 8 Nov 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout